SpectraCure presents results from Phase 1 study
SpectraCure presents results from the company's Phase 1 study at The 17th International Photodynamic Association World Congress in Boston.SpectraCure (publ) will present results from the company's Phase 1 study at the International Photodynamic Association World Congress arranged June 28th - July 4th in Boston, Massachusetts, USA. The presentation will be held by Johannes Swartling, CTO.- We look forward to presenting the results from the Phase 1 study at a world conference and it is very exciting to share the successful result from SpectraCure's Phase 1 study with world-leading clinical